Oscar Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $691.1M | $706.2M | $511.0M | $521.6M | $534.5M | $482.8M | $465.8M | $460.4M |
| Operating Income | $388.6M | $704.1M | $-333.7M | $-129.3M | $-230.5M | $297.1M | $-147.7M | $-48.4M |
| Operating Margin | 8.0% | 15.2% | -11.9% | -4.3% | -8.0% | 9.8% | -6.2% | -2.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $383.0M | $698.8M | $-352.7M | $-139.3M | $-233.5M | $288.2M | $-153.7M | $-52.3M |
| Income Tax Expense | $21.2M | $19.8M | $-247.0K | $-1.8M | $-5.0M | $12.7M | $-404.0K | $2.1M |
| Net Income | $361.8M | $679.0M | $-352.6M | $-137.5M | $-228.4M | $275.3M | $-153.5M | $-54.6M |
| Net Margin | 7.4% | 14.6% | -12.6% | -4.6% | -8.0% | 9.0% | -6.4% | -2.3% |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 |
| Shares Outstanding (Basic) | 302.2M | 298.2M | 262.4M | 259.3M | 255.5M | 251.3M | 240.4M | 243.1M |
| Shares Outstanding (Diluted) | 333.4M | 329.8M | 262.4M | 259.3M | 255.5M | 305.9M | 265.9M | 243.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |